Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 4;9(3):355.
doi: 10.3390/children9030355.

Pleuropulmonary MDCT Findings: Comparison between Children with Pulmonary Vein Stenosis and Prematurity-Related Lung Disease

Affiliations

Pleuropulmonary MDCT Findings: Comparison between Children with Pulmonary Vein Stenosis and Prematurity-Related Lung Disease

Abbey J Winant et al. Children (Basel). .

Abstract

Purpose: To retrospectively compare the pleuropulmonary MDCT findings in children with pulmonary vein stenosis (PVS) and prematurity-related lung disease (PLD). Materials and Methods: All consecutive infants and young children (≤18 years old) who underwent thoracic MDCT studies from July 2004 to November 2021 were categorized into two groups—children with PVS (Group 1) and children with PLD without PVS (Group 2). Two pediatric radiologists independently evaluated thoracic MDCT studies for the presence of pleuropulmonary abnormalities as follows—(1) in the lung (ground-glass opacity (GGO), triangular/linear plaque-like opacity (TLO), consolidation, nodule, mass, cyst(s), interlobular septal thickening, and fibrosis); (2) in the airway (bronchial wall thickening and bronchiectasis); and (3) in the pleura (thickening, effusion, and pneumothorax). Interobserver agreement between the two reviewers was evaluated with the Kappa statistic. Results: There were a total of 103 pediatric patients (60 males (58.3%) and 43 females (41.7%); mean age, 1.7 years; range, 2 days−7 years). Among these 103 patients, 49 patients (47.6%) comprised Group 1 and the remaining 54 patients (52.4%) comprised Group 2. In Group 1, the observed pleuropulmonary MDCT abnormalities were—pleural thickening (44/49; 90%), GGO (39/49; 80%), septal thickening (39/49; 80%), consolidation (4/49; 8%), and pleural effusion (1/49; 2%). The pleuropulmonary MDCT abnormalities seen in Group 2 were—GGO (45/54; 83%), TLO (43/54; 80%), bronchial wall thickening (33/54; 61%), bronchiectasis (30/54; 56%), cyst(s) (5/54; 9%), pleural thickening (2/54; 4%), and pleural effusion (2/54; 4%). Septal thickening and pleural thickening were significantly more common in pediatric patients with PVS (Group 1) (p < 0.001). TLO, bronchial wall thickening, and bronchiectasis were significantly more frequent in pediatric patients with PLD without PVS (Group 2) (p < 0.001). There was high interobserver kappa agreement between the two independent reviewers for detecting pleuropulmonary abnormalities on thoracic MDCT angiography studies (k = 0.99). Conclusion: Pleuropulmonary abnormalities seen on thoracic MDCT can be helpful for distinguishing PVS from PLD in children. Specifically, the presence of septal thickening and pleural thickening raises the possibility of PVS, whereas the presence of TLO, bronchial wall thickening and bronchiectasis suggests PLD in the pediatric population.

Keywords: children; multidetector computed tomography (MDCT); pediatric patients; pleuropulmonary findings; prematurity-related lung disease; pulmonary vein stenosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Fourteen-month-old girl with right sided pulmonary vein stenosis. (a): Axial lung window CT image demonstrates septal thickening (arrowheads) and pleural thickening (arrows) in the right hemithorax. (b): Axial contrast-enhanced soft tissue window CT image shows pleural thickening (arrows) in the right hemithorax. Right pulmonary veins are absent. Left pulmonary vein (asterisk) is visualized.
Figure 2
Figure 2
Histologic findings in pulmonary vein stenosis. After death at age 13 months, this patient’s pulmonary veins showed fibrous intimal proliferation (left panel; hematoxylin and eosin; original magnification, 40×). The pleura (arrows) and interlobular septum were thickened, containing distended and tortuous veins (V) and thick-walled lymphatic channels (L) (right panel; hematoxylin and eosin; original magnification, 100×).
Figure 3
Figure 3
Three-year-old girl with prematurity-related lung disease. (a): Axial lung window CT image shows triangular/linear plaque-like opacity (arrows) in both lungs. Pleural based atelectasis (arrowheads) is also seen. However, no pleural thickening is noted. (b): Axial lung window CT image demonstrates bronchial wall thickening (arrowhead) and bronchiectasis (arrow).
Figure 4
Figure 4
Histology in prematurity-related lung disease. Wedge biopsy sample from a 2-year-old girl born at 32 and 5/7 weeks’ gestational age shows small airway remodeling, smooth muscle proliferation, and enlarged airspaces. The pleura (arrows) were thin and delicate without pathological evidence for thickening. (Hematoxylin and eosin; original magnification, 100×).

Similar articles

Cited by

References

    1. Humpl T., Fineman J., Qureshi A.M. The many faces and outcomes of pulmonary vein stenosis in early childhood. Pediatr. Pulmonol. 2020;56:649–655. doi: 10.1002/ppul.24848. - DOI - PubMed
    1. Backes C.H., Nealon E., Armstron A.K., Cua C.L., Mitchell C., Krishnan U., Vanderlaan R.D., Song M.K., Viola N., Smith C.V., et al. Pulmonary vein stenosis in infants: A systemic review, meta-analysis, and meta-regression. J Pediatr. 2018;198:36–45. doi: 10.1016/j.jpeds.2018.02.030. - DOI - PubMed
    1. Frank D.B., Levy P.T., Stiver C.A., Boe B.A., Baird C.W., Callahan R.M., Smith C.V., Vanderlaan R.D., Backes C.H. Primary pulmonary vein stenosis during infancy: State of the art review. J. Perinatol. 2021;41:1528–1539. doi: 10.1038/s41372-021-01008-7. - DOI - PubMed
    1. Suntharos P., Prieto L.R. Treatment of Congenital and Acquired Pulmonary Vein Stenosis. Curr. Cardiol. Rep. 2020;22:153. doi: 10.1007/s11886-020-01395-x. - DOI - PubMed
    1. Samuel M., Khairy P., Mongeon F.-P., Andrade J.G., Gomes S., Galvan Z., Weerasooriya R., Novak P., Nault I., Arentz T., et al. Pulmonary Vein Stenosis After Atrial Fibrillation Ablation: Insights from the ADVICE Trial. Can. J. Cardiol. 2020;36:1965–1974. doi: 10.1016/j.cjca.2020.10.013. - DOI - PubMed